Filing Details
- Accession Number:
- 0001179110-18-008426
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-12 20:55:09
- Reporting Period:
- 2018-06-11
- Accepted Time:
- 2018-06-12 20:55:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1157601 | Madrigal Pharmaceuticals Inc. | MDGL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1423898 | Rebecca Taub | C/O Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 400 West Conshohocken PA 19428 | Chief Medical Officer, Evp R&D | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-06-11 | 73,526 | $287.46 | 655,540 | No | 4 | S | Indirect | By SQN, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By SQN, LLC |
Footnotes
- The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.